What Technoclone does

Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH is a Vienna-based, privately held in vitro diagnostics company founded in 1987 by Prof. Dr. Bernd R. Binder. The company specializes in coagulation and fibrinolysis diagnostics, manufacturing both instruments and reagents that clinical laboratories use to diagnose and monitor bleeding, thrombophilic, and anticoagulated patients. Its core technology stack combines proprietary ELISA systems (Actibind for simultaneous activity and antigen determination), the first CE-marked thrombin generation assays (Technothrombin TGA / Ceveron TGA), and the Ceveron analyzer platform — including the fully automated s100/t100/c100 series with the world's first quenching module for automated FXIII and ADAMTS13 testing, and the semi-automated m1/m2/m4 line.

The company's product portfolio spans the full hemostasis workflow: global coagulation tests (PT/aPTT/D-Dimer), factor assays, von Willebrand disease and TTP diagnostics (including FDA-cleared ADAMTS13), anticoagulant treatments including DOAC testing, thrombophilia and fibrinolysis markers, thrombin generation reagents, and research-only proteins and antibodies. Products are marketed under multiple sub-brands (Ceveron, TECHNOZYM, TECHNOLEIA, Technochrom, Technothrombin TGA, Actibind), creating distinct positioning across clinical and research use cases.

Technoclone operates a multi-channel go-to-market: a worldwide distributor network for clinical products, a dedicated direct sales operation in the UK, an OEM/private-label channel that supplies major international diagnostic companies with rebranded test systems, and a research-products catalog sold through its own website and academic partners. Regulatory positioning is a meaningful asset, with ISO 13485:2016, ISO 9001:2015, and MDSAP certifications (the latter enabling audit-efficient access to USA, Canada, Brazil, Japan, and Australia), CE-marking for EU clinical products, and FDA clearance for ADAMTS13 Activity. Pricing is quote-based rather than publicly disclosed, and the customer base spans clinical diagnostic laboratories, academic and research institutions, and OEM diagnostic manufacturers.

Name

Technoclone

Legal name

Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH

Website

https://technoclone.com

Company type

Private

Founded year

1987

Operating status

Operating

Short description

Technoclone is a Vienna-based, privately held in vitro diagnostics company founded in 1987 that develops and manufactures coagulation and fibrinolysis tests, reagents, and automated analyzers (Ceveron series) for clinical laboratories, academic researchers, and OEM diagnostic partners worldwide.

Ownership category

akta.pro rank

Product category

Coagulation and Fibrinolysis Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Hematology & Coagulation Diagnostics (HLAHAAAB)

akta.pro secondary industries

Release Testing & Batch Certification (QC) (HLAGADAC), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

Keywords

• Coagulation diagnostics
• Hemostasis analyzers
• Thrombin generation assays
• Fibrinolysis ELISA kits
• In vitro diagnostics

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Diagnostic Tests and Reagents: Technoclone manufactures and sells diagnostic tests for coagulation and fibrinolysis including ELISA kits, latex immunoassays, and chromogenic assays. Products include D-Dimer tests, coagulation factor assays, fibrinolysis markers (t-PA, u-PA, PAI-1), and specialized tests like ADAMTS13 activity.
2. Coagulation Instruments: Sale of automated and semi-automated coagulation analyzers (Ceveron series: s100, t100, c100, m1, m2, m4, MFU500) along with consumables, cuvettes, reagents, and accessories.
3. OEM Products: High-quality test systems and reagents manufactured by Technoclone are sold not only under the Technoclone name worldwide but also as OEM products with major international diagnostic companies.
4. Research Products: Sale of research-use-only products including fibrinolysis-related proteins and antibodies for research purposes.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Technoclone manufactures and sells in vitro diagnostic tests, automated and semi-automated coagulation analyzers (Ceveron series), and research-use reagents for the diagnosis and monitoring of hemostasis (blood clotting) and fibrinolysis disorders. Its product range covers routine coagulation assays, specialized thrombin generation tests, fibrinolysis ELISA panels, D-Dimer testing, and supporting auxiliary reagents, sold to clinical laboratories, hospitals, research institutions, and OEM diagnostic partners worldwide.

Product overview

Technoclone is a Vienna-based diagnostics company founded in 1987 specializing in in vitro diagnostics for hemostasis and fibrinolysis. The product portfolio centers on the Ceveron instrument family (fully automated 100 Series: c100, t100, s100; semi-automated m Series: m1, m2, m4; and MFU500 filtration unit) and a comprehensive range of diagnostic reagents and assays. The Ceveron 100 Series instruments offer fully automated coagulation testing including clotting, chromogenic, turbidimetric assays, and thrombin generation (TGA), with the s100 model additionally featuring quenching technology for automated FXIII and ADAMTS13 activity testing. The company offers Technothrombin TGA reagents for microplate readers (RUO) and Ceveron TGA Kits (CE-marked) for automated instruments. Diagnostic assays include D-Dimer testing (TECHNOLEIA), fibrinolysis panels (TECHNOZYM ELISAs for t-PA, PAI-1, u-PA, PAP Complex, Glu-Plasminogen, Protein C Inhibitor, t-PA-PAI-1 Complex), and Technochrom chromogenic assays for plasminogen and plasmin inhibitor. The portfolio also includes general and Ceveron-specific auxiliary reagents. Products are distributed globally under the Technoclone brand and as OEM products through other major diagnostic companies.

Differentiator

Problem solved

Functional benefit

Brands

• Ceveron: Fully and semi-automated coagulation analyzers for clinical diagnostics including Ceveron s100, t100, c100, and m-series instruments
• TECHNOZYM
• TECHNOLEIA
• Technochrom
• Technothrombin TGA
• Actibind

Products and services

• Ceveron s100 Fully automated coagulation analyzer for clinical laboratories performing clotting, chromogenic, turbidimetric assays, TGA, and quenching assays; world's first fully automated hemostasis analyzer with quenching technology capable of automated FXIII and ADAMTS13 activity testing from a single sample.
• Ceveron t100 Fully automated coagulation analyzer for clotting, chromogenic, turbidimetric assays, and thrombin generation testing in clinical laboratories.
• Ceveron c100 Fully automated coagulation analyzer for clotting, chromogenic, and turbidimetric assays in clinical laboratories.
• Ceveron m1 Semi-automated coagulation analyzer with one optical channel (620nm), for whole blood and citrate plasma samples in clinical laboratories.
• Ceveron m2 Semi-automated coagulation analyzer with two optical channels at 405nm (UV), for citrate plasma samples in clinical laboratories.
• Ceveron m4 Semi-automated coagulation analyzer with four optical channels at 405nm (UV), for citrate plasma samples in clinical laboratories.
• Ceveron MFU500 Microparticle Filtration Unit (MFU) 500 enabling quick and standardized removal of microparticles from platelet poor plasma, with effectiveness comparable to ultra-centrifugation.
• Ceveron TGA Kits CE-marked thrombin generation assay kits (RB, RC Low, RC High) optimized for Ceveron t100 and s100 instruments, measuring bleeding, thrombophilic, and anticoagulated tendencies.
• Technothrombin TGA Research-use-only thrombin generation reagents for fluorescence microplate readers, available in kit format with multiple triggers and as modular reagents (RA, RB, RC Low, RC High, IVIG, RD, SUB).
• TECHNOLEIA D-Dimer Latex Kit Latex-enhanced immunoassay for quantitative D-Dimer determination used in clinical laboratories for exclusion diagnosis of deep venous thrombosis, pulmonary embolism, DIC, thrombolytic treatment monitoring, and cancer diagnostics.
• TECHNOZYM t-PA EDTA ELISA Kit Sandwich ELISA kit for quantitative determination of tissue plasminogen activator (t-PA) in human plasma, detecting both complexed and uncomplexed forms.
• TECHNOZYM PAI-1 Antigen ELISA Kit Sandwich ELISA detecting active, latent, and t-PA-PAI-1 complex forms of plasminogen activator inhibitor-1 (PAI-1) in plasma.
• TECHNOZYM PAI-1 Actibind ELISA Kit Highly sensitive ELISA for quantitative determination of active PAI-1 antigen in human plasma based on Actibind functional t-PA immobilization technology.
• TECHNOZYM u-PA ELISA Kit Sandwich ELISA for quantitative determination of urokinase-type plasminogen activator (u-PA) in human plasma and tissue extracts, detecting both single and double chain urokinase.
• TECHNOZYM u-PA Combi Actibind ELISA Kit Combined ELISA using Actibind technology for simultaneous quantitative determination of u-PA concentration and activity in human plasma.
• TECHNOZYM PAP Complex ELISA Kit ELISA kit for determination of Plasmin-alpha-2-Antiplasmin complex (PAP) concentration in plasma, using a monoclonal antibody specific for the neoantigenic site on the complex.
• TECHNOZYM Glu-Plasminogen ELISA Kit Sandwich ELISA for selective quantitative determination of Glu-Plasminogen in human plasma using monoclonal antibodies specific for the native Glu-form.
• TECHNOZYM Protein C Inhibitor Actibind ELISA Kit

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Baxter AG (former Immuno Diagnostika)coreStrategic or Co-development PartnerIn 1998, Technoclone acquired the product portfolio of the former Immuno Diagnostika from Baxter AG, enabling rapid expansion and establishment as a global diagnostics company.
• OEM Diagnostic PartnerscoreOEM/ Whitelabel/ Licensing PartnerHigh-quality test systems and reagents manufactured by Technoclone are sold as OEM products with major international diagnostic firms, distributed under their own brand names.
• Universities and Research ConsortiacoreStrategic or Co-development PartnerResearch and development conducted in collaboration with universities and international and national research consortia in the field of thrombosis and cardiovascular diseases.
• ECTH (European Congress on Thrombosis and Haemostasis)minorStrategic or Co-development PartnerSince 2023, the BRB Award (Bernd R. Binder Publication Prize) has been part of the ECTH congress, bringing together researchers, scientists, clinicians, and other medical professionals for thrombosis and hemostasis education.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Trinity Biotech: Specialty IVD company with a hemostasis product line including coagulation analyzers and reagents, comparable in scale and niche focus to Technoclone.
• Diagnostica Stago: Privately held French company and a global leader in hemostasis diagnostics, offering automated coagulation analyzers and a comprehensive reagent menu closely overlapping Technoclone's Ceveron instruments and coagulation/fibrinolysis kits.
• Werfen (Instrumentation Laboratory): Specialized hemostasis division (IL) with the ACL TOP family of coagulation analyzers and broad specialty reagents, directly competing with Technoclone in routine and specialty coagulation testing for clinical labs.
• Helena Laboratories: Privately held specialty IVD company focused on hemostasis and thrombophilia testing, offering analyzers and reagents that directly compete with Technoclone's coagulation portfolio.

Emerging players

• Enzyme Research Laboratories: Niche coagulation research reagent supplier (proteins, antibodies) with a similar customer base to Technoclone's research products and fibrinolysis research offerings.
• Stago (OEM) / Stago reference suppliers: Reference hemostasis reagent and analyzer partners in the coagulation specialty channel, adjacent peers that overlap in the fibrinolysis, TGA, and ADAMTS13 niches Technoclone targets.

Broad incumbents

• Roche Diagnostics: Broad incumbent with cobas t-series coagulation analyzers and reagents, competing in routine hemostasis and increasingly in specialty assays relevant to Technoclone's portfolio.
• Siemens Healthineers (Dade Behring hemostasis): Broad incumbent with the Sysmex-derived hemostasis franchise (CA-series analyzers) and deep reagent portfolio, serving the same clinical labs as Technoclone but as part of a much wider diagnostics portfolio.
• Sysmex: Major hematology and hemostasis analyzer vendor with a broad installed base; competes with Technoclone's Ceveron series in mid- and high-volume coagulation testing.
• Abbott (Diagnostics): Broad incumbent with coagulation/immunoassay platforms (Architect, Alinity ci-series) that overlap with Technoclone's clinical laboratory customers and hemostasis test menu.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/technoclone
• Facebookfacebook.com/technoclone
• LinkedInlinkedin.com/company/technoclone-gmbh-vienna-austria

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Technoclone